Page last updated: 2024-09-03

pd 142893 and dactinomycin

pd 142893 has been researched along with dactinomycin in 1 studies

Compound Research Comparison

Studies
(pd 142893)
Trials
(pd 142893)
Recent Studies (post-2010)
(pd 142893)
Studies
(dactinomycin)
Trials
(dactinomycin)
Recent Studies (post-2010) (dactinomycin)
640319,045355969

Protein Interaction Comparison

ProteinTaxonomypd 142893 (IC50)dactinomycin (IC50)
RAD51Homo sapiens (human)32.1
Growth factor receptor-bound protein 2Homo sapiens (human)5
Discoidin domain-containing receptor 2Homo sapiens (human)9
Growth factor receptor-bound protein 2 Mus musculus (house mouse)5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desai, D; He, S; Krishnamoorthy, RR; Prasanna, G; Yorio, T1

Other Studies

1 other study(ies) available for pd 142893 and dactinomycin

ArticleYear
Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes.
    Biochemical and biophysical research communications, 2004, Jun-04, Volume: 318, Issue:3

    Topics: Aged; Aged, 80 and over; Aspartic Acid Endopeptidases; Astrocytes; Butadienes; Cell Division; Cell Hypoxia; Cell Line, Tumor; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glycopeptides; Humans; Metalloendopeptidases; Mitogen-Activated Protein Kinases; Nitriles; Oligopeptides; Optic Disk; Protease Inhibitors; Tumor Necrosis Factor-alpha

2004